Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many ...

AI for Automation and Digital Data Flow

AI for Automation and Digital Data Flow

June 24th, 2026 1 minute read

Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s...